BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35101972)

  • 1. ASK1 signaling regulates phase-specific glial interactions during neuroinflammation.
    Guo X; Kimura A; Namekata K; Harada C; Arai N; Takeda K; Ichijo H; Harada T
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35101972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASK1 activation in glial cells in post-mortem multiple sclerosis tissue.
    Seki E; Guo X; Namekata K; Komori T; Hayashi H; Arai N; Harada T
    Neuropathology; 2024 May; ():. PubMed ID: 38775061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
    Kim RY; Hoffman AS; Itoh N; Ao Y; Spence R; Sofroniew MV; Voskuhl RR
    J Neuroimmunol; 2014 Sep; 274(1-2):53-61. PubMed ID: 25005117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional knockout of ASK1 in microglia/macrophages attenuates epileptic seizures and long-term neurobehavioural comorbidities by modulating the inflammatory responses of microglia/macrophages.
    Zhang Y; Wang Z; Wang R; Xia L; Cai Y; Tong F; Gao Y; Ding J; Wang X
    J Neuroinflammation; 2022 Aug; 19(1):202. PubMed ID: 35941644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway.
    Guo X; Harada C; Namekata K; Matsuzawa A; Camps M; Ji H; Swinnen D; Jorand-Lebrun C; Muzerelle M; Vitte PA; Rückle T; Kimura A; Kohyama K; Matsumoto Y; Ichijo H; Harada T
    EMBO Mol Med; 2010 Dec; 2(12):504-15. PubMed ID: 21064192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-β signaling.
    Wu Q; Miao X; Zhang J; Xiang L; Li X; Bao X; Du S; Wang M; Miao S; Fan Y; Wang W; Xu X; Shen X; Yang D; Wang X; Fang Y; Hu L; Pan X; Dong H; Wang H; Wang Y; Li J; Huang Z
    Theranostics; 2021; 11(17):8480-8499. PubMed ID: 34373754
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.
    Han J; Zhu K; Zhou K; Hakim R; Sankavaram SR; Blomgren K; Lund H; Zhang XM; Harris RA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid and ASK1 deficiency ameliorate optic neuritis and neurodegeneration in an animal model of multiple sclerosis.
    Azuchi Y; Kimura A; Guo X; Akiyama G; Noro T; Harada C; Nishigaki A; Namekata K; Harada T
    Neurosci Lett; 2017 Feb; 639():82-87. PubMed ID: 28040492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
    Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
    J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.
    Griffiths MR; Botto M; Morgan BP; Neal JW; Gasque P
    Immunology; 2018 Nov; 155(3):346-355. PubMed ID: 29923617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis.
    Rajasundaram S
    Front Immunol; 2018; 9():402. PubMed ID: 29559972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-β therapy.
    Mimouna S; Rollins DA; Shibu G; Tharmalingam B; Deochand DK; Chen X; Oliver D; Chinenov Y; Rogatsky I
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Chu F; Shi M; Zheng C; Shen D; Zhu J; Zheng X; Cui L
    J Neuroimmunol; 2018 May; 318():1-7. PubMed ID: 29606295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE).
    Munro KM; Dixon KJ; Gresle MM; Jonas A; Kemper D; Doherty W; Fabri LJ; Owczarek CM; Pearse M; Boyd AW; Kilpatrick TJ; Butzkueven H; Turnley AM
    PLoS One; 2013; 8(2):e55948. PubMed ID: 23390555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis.
    Ma C; Li S; Hu Y; Ma Y; Wu Y; Wu C; Liu X; Wang B; Hu G; Zhou J; Yang S
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33710283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS.
    Li Z; Korhonen EA; Merlini A; Strauss J; Wihuri E; Nurmi H; Antila S; Paech J; Deutsch U; Engelhardt B; Chintharlapalli S; Koh GY; Flügel A; Alitalo K
    J Clin Invest; 2020 Apr; 130(4):1977-1990. PubMed ID: 32149735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
    Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
    Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.